AngioDynamics (NASDAQ:ANGO), a leading provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology, has seen a dramatic turnaround in its business this year. The company anticipates that its earnings will progressively improve each quarter because of higher revenue and stronger margins of its new products. I feel that ANGO's share price will see a gradual up move from the current level. In this investment thesis I will focus on the opportunities that lie ahead of ANGO.
AngioDynamics manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers. The devices are generally used in minimally invasive, image-guided procedures. Most of the products of ANGO are intended to...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|